hero image
Dr. Kiran Rabheru - International Federation on Ageing. Ottawa, ON, CA

Dr. Kiran Rabheru Dr. Kiran Rabheru

Full Professor of Psychiatry | University of Ottawa

Ottawa, ON, CANADA

Dr. Kiran Rabheru is a Full Professor of Psychiatry at the University of Ottawa and Geriatric Psychiatrist at The Ottawa Hospital (TOH).

Media

Publications:

Documents:

Photos:

loading image

Videos:

Electroconvulsive therapy (ECT) Training Human Rights of Older Persons: Social Cost of Ageism Webinar Mar 18 A Statement from Dr Kiran Rabheru (ILC Canada/GAROP) - Age with Rights! Towards a Convention on the Human Rights of Older Persons

Audio:

Social

Biography

Dr. Kiran Rabheru is a Full Professor of Psychiatry at the University of Ottawa and Geriatric Psychiatrist at The Ottawa Hospital (TOH). He serves as Medical Director of the Geriatric Psychiatry, Electroconvulsive Therapy (ECT), and the Behavioral Support Programs at TOH. He obtained his medical degree (MD) from University of Western Ontario. He is a Certificant and Fellow of the College of Family Physicians of Canada (CCFP, FCFP). First, as a Family Physician, he gained real life experience working in several rural and urban settings for 5 years. Subsequently, he went on to complete his specialty training in Psychiatry, subspecializing in Geriatric Psychiatry, in which he is Board Certified in Canada (FRCP) and the United States (DABPN).

Dr. Rabheru is passionate and committed to serving older persons and is recognized nationally and internationally for his work. He is designated as a Founder of the subspecialty of Geriatric Psychiatry by the Royal College of Physicians and Surgeons of Canada. He is recipient of the Outstanding Achievements in Geriatric Psychiatry in Canada award by the Canadian Academy of Geriatric Psychiatry (www.cagp.ca) and has served as its President of the CAGP and a member of its Board for many years. He serves as a Co-Leader of the Canadian Coalition for Seniors’ Mental Health (https://ccsmh.ca/), Chair of the Board of the International Longevity Centre (www.ilccanada.org), Board member of the International Psychogeriatric Association (www.ipa-online.org ), Chair of the Section of Positive Psychiatry of the World Psychiatric Association (https://www.wpanet.org/) and a member of the National Leadership Team for the Fountain of Health (www.fountainofhealth.ca), which promotes healthy aging, brain resilience and vitality. In November 2020, Dr. Rabheru was honoured to be elected as Chair of the Steering Committee for the Global Alliance for the Rights of Older People – GAROP (https://rightsofolderpeople.org), a network of over 380 members from over 80 counties worldwide, united in the work to strengthen and promote the rights and the voice of older persons globally. The Global Alliance for the Rights of Older People seeks a world in which older persons live free from discrimination and are able to fully enjoy their rights.

Areas of Expertise (5)

Mental Health

Dementia

Geriatric Psychiatry

Late Onset Psychosis

Psychiatry

Accomplishments (6)

The Ottawa Hospital Guardian Angel Award (professional)

2020

The Ottawa Hospital Guardian Angel Award (professional)

2014

Canadian Certified Physician Executive (CCPE) (professional)

2014 Canadian Medical Association and the Canadian Society of Physician Executives

R. O. Jones Award (professional)

September 2013 Canadian Psychiatric Association (CPA) Annual Meeting

The Ottawa Hospital (TOH) Quality Award (professional)

2012/2013

Canadian Academy of Geriatric Psychiatry (CAGP) Award for Outstanding Achievements in Geriatric Psychiatry in Canada (professional)

2012

Education (2)

University of Western Ontario: B.Sc. Honours, Microbiology and Immunology 1976

University of Western Ontario: M.D. 1980

Affiliations (5)

  • Global Alliance for the Rights of Older People (GAROP) : Chair – Steering Committee
  • International Longevity Center (Global Alliance) : Member
  • International Psychogeriatric Association (IPA) : Member
  • World Psychiatric Association : Executive Committee Member
  • International Longevity Center (ILC-Canada) : Founding Board Member and Chair

Media Appearances (2)

Robot helps deliver “shocking” world first

The Ottawa Hospital  online

2021-03-05

Mr. Smith, a robotic mannequin, helped Dr. Kiran Rabheru provide a shocking new world’s-first course for psychiatrists recently – hands-on training to administer electroconvulsive therapy (ECT).

view more

TOH pioneers geriatric psychiatry acute care in Ontario

The Ottawa Hospital  online

2013-11-13

“If it works here, it’ll be rolled out elsewhere,” said Dr. Kiran Rabheru, Medical Director of Geriatric Psychiatry. “To our knowledge, we are the first in Ontario to have these full-time dedicated nurses in acute care. It’s new and innovative.”

view more

Event Appearances (5)

Transforming Healthcare for Dementia Prevention: Health Behavior Change as First Line Medicine

International Psychogeriatric Association 19th IPA Congress  Santiago de Compostela, Spain

2019-08-31

Ageism: Why We Need a United Nations Convention on the Rights of Older Persons

International Psychogeriatric Association 19th IPA Congress  Santiago de Compostela, Spain

2019-08-31

Canadian Guidelines for Older Adults: Prevention, Assessment and Treatment of Alcohol, Benzodiazepine, Cannabis and Opioid Use Disorders

International Psychogeriatric Association 19th IPA Congress  Santiago de Compostela, Spain

2019-08-31

Emerging Trends in Preventing Dementia at a Global Level

International Psychogeriatric Association 19th IPA Congress  Santiago de Compostela, Spain

2019-08-31

Addressing the impact of cognitive frailty and dementia on the rehabilitation of older adults

International Psychogeriatric Association's (IPA) Pre-congress course  Montreal, Canada

2018-11-01

Research Grants (3)

A National Cannabis (E-Learning) Education Program Focused on Older Adults

Health Canada: Substance Use and Addictions Division, Controlled Rabheru K Curriculum Vitae 66 Substances and Cannabis Branch $856,945

2019 - 2022 David Conn, K. Rabheru, et al.

Fountain of Health Initiative for Brain Health & Optimal Aging: Innovative Practice Tools for Health Behavior Change & Dementia Prevention

Centre for Aging and Brain Health Innovation $425,000

2018 - 2019 K. Rabheru (PI), KL Cassidy (Co-PI), et al.

Development of Four National Guidelines for Older Adults: Prevention, Assessment, & Treatment of Alcohol, Opioids, Benzodiazepines and Cannabis Use Disorders.

Health Canada - Substance Use and Addiction Program $960,151.00

2017 - 2020 Dr. David Conn (PI) and K. Rabheru (Co-Investigator) et al.

Featured Articles (5)

Loneliness and social isolation during the COVID-19 pandemic

International Psychogeriatrics

The COVID-19 pandemic has led to implementation of unprecedented “social distancing” strategies crucial to limiting the spread of the virus. In addition to quarantine and isolation procedures for those who have been exposed to or infected with COVID-19, social distancing has been enforced amongst the general population to reduce the transmission of COVID-19.

view more

Comparing a clinician-assisted and app-supported behavioral activation intervention to promote brain health and well-being in frontline care

International Psychogeriatrics

Positive psychiatry offers an unique approach to promote brain health and well-being in aging populations. Minimal interventions through behavioral activation to promote wellness are increasingly available using self-guided apps, yet little is known about the effectiveness of app technology or the difference between clinician-supported behavioral activation versus self-guided app methodologies.

view more

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067148/

Canadian Geriatrics Journal

In Canada, rates of hospital admission from opioid overdose are higher for older adults (≥ 65) than younger adults, and opioid use disorder (OUD) is a growing concern. In response, Health Canada commissioned the Canadian Coalition of Seniors’ Mental Health to create guidelines for the prevention, screening, assessment, and treatment of OUD in older adults.

view more

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis

Schizophrenia Research and Treatment

Treatment of schizophrenia with first- and second-generation antipsychotics has been associated with elevated prolactin levels, which may increase the risk for prolactin-related adverse events.

view more

Some of the CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression Are Not Congruent with Available Evidence or Expert Opinion

The Canadian Journal of Psychiatry

The Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines have become important references for clinicians and learners in Canada and elsewhere. Thus, we welcome the publication in the Canadian Journal of Psychiatry of new guidelines focusing on special populations, including a well-written section on the treatment of late-life depression.

view more